rs61732194
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_021098.3(CACNA1H):c.5494C>G(p.Leu1832Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000415 in 1,398,714 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L1832L) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.5494C>G | p.Leu1832Val | missense_variant | Exon 33 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.5509C>G | p.Leu1837Val | missense_variant | Exon 32 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.5512C>G | p.Leu1838Val | missense_variant | Exon 32 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.5476C>G | p.Leu1826Val | missense_variant | Exon 32 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.5509C>G | p.Leu1837Val | missense_variant | Exon 33 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.5494C>G | p.Leu1832Val | missense_variant | Exon 33 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.5455C>G | p.Leu1819Val | missense_variant | Exon 33 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.5476C>G | p.Leu1826Val | missense_variant | Exon 32 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.5437C>G | p.Leu1813Val | missense_variant | Exon 32 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.5494C>G | p.Leu1832Val | missense_variant | Exon 33 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.5476C>G | p.Leu1826Val | missense_variant | Exon 32 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.5494C>G | p.Leu1832Val | missense_variant | Exon 33 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.5494C>G | p.Leu1832Val | missense_variant | Exon 33 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.5494C>G | p.Leu1832Val | missense_variant | Exon 33 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.5494C>G | non_coding_transcript_exon_variant | Exon 33 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*1446C>G | non_coding_transcript_exon_variant | Exon 32 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*575C>G | non_coding_transcript_exon_variant | Exon 33 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*3345C>G | non_coding_transcript_exon_variant | Exon 33 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4938C>G | non_coding_transcript_exon_variant | Exon 31 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*468C>G | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*353C>G | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*1106C>G | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*161C>G | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*161C>G | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.5476C>G | non_coding_transcript_exon_variant | Exon 32 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.5494C>G | non_coding_transcript_exon_variant | Exon 33 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.5494C>G | non_coding_transcript_exon_variant | Exon 33 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*610C>G | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*1446C>G | 3_prime_UTR_variant | Exon 32 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*575C>G | 3_prime_UTR_variant | Exon 33 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*3345C>G | 3_prime_UTR_variant | Exon 33 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4938C>G | 3_prime_UTR_variant | Exon 31 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*468C>G | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*353C>G | 3_prime_UTR_variant | Exon 33 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*1106C>G | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*161C>G | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*161C>G | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*610C>G | 3_prime_UTR_variant | Exon 33 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.0000191 AC: 3AN: 157360 AF XY: 0.0000120 show subpopulations
GnomAD4 exome AF: 0.0000415 AC: 58AN: 1398714Hom.: 0 Cov.: 32 AF XY: 0.0000377 AC XY: 26AN XY: 689960 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.5494C>G (p.L1832V) alteration is located in exon 33 (coding exon 32) of the CACNA1H gene. This alteration results from a C to G substitution at nucleotide position 5494, causing the leucine (L) at amino acid position 1832 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1832 of the CACNA1H protein (p.Leu1832Val). This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 1381746). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1H protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at